It has been shown that post‐mortem studies of brain tissue from patients with AD provided a relevant increase in NF‐κB activity in cells involved in the neurodegenerative process: p65 immunoreactivity increases in neurons and astrocytes close to amyloid plaques in brain sections from patients with AD 26. The gene discussed is NFKB1; the disease is Alzheimer disease.